LINC01695

Across TCGA pan-cancer cohorts, LINC01695 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01695’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01695 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01695 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KICH, and READ are the cancer types where LINC01695 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01695 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.187	<.001	11	view →
KICH	Female	All	−0.099	<.001	8	view →
READ	All	III,IV	−0.035	.019	5	view →
BRCA	All	II,III,IV	+0.077	.009	4	view →
HNSC	All	All	+0.050	.027	4	view →
COAD	Male	II,III,IV	−0.034	.009	4	view →
LUSC	All	All	+0.060	.003	3	view →
BLCA	All	IV	−0.382	.005	2	view →
ESCA	All	All	−0.158	.005	2	view →
PRAD	All	All	−0.110	.042	2	view →
LIHC	All	III,IV	−0.006	.012	2	view →
CHOL	Male	All	+0.076	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01695–THCA

Open the THCA breakdown →